Letters
Gender dysphoria
Gender dysphoria: scientific oversight falling between responsible institutions should worry us all
BMJ 2019; 367 doi: https://doi.org/10.1136/bmj.l6439 (Published 04 December 2019) Cite this as: BMJ 2019;367:l6439
- Richard Byng, professor in primary care research and general practitioner1,
- Susan Bewley, emeritus professor of obstetrics and women’s health2
- 1Community and Primary Care Research Group, University of Plymouth, Plymouth Science Park, Plymouth PL6 8BX, UK
- 2King’s College London, London, UK
- richard.byng{at}plymouth.ac.uk
The troubles around the Gender Identity Development Service’s study12 seem to be symptomatic of our wider collective failure to determine whether, and when, we should prescribe puberty blockers, or cross sex hormones, to children and young people identifying as transgender.
The ethics of research conduct belongs to the Health Research Authority (HRA), and the quality of science is an important consideration when …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.